Figure 2.
MRPA incidence rates in ICUs during and after the implementation of the restricted use of carbapenems. Bars: incidence rates (n° MRPA cases/1,000 patient-days). Line: DDD carbapenem use/1,000 patient-days.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.